Literature DB >> 22282522

Deus ex Candida genetics: overcoming the hurdles for the development of a molecular toolbox in the CTG clade.

Nicolas Papon1, Vincent Courdavault1, Marc Clastre1, Andrew J Simkin1, Joël Crèche1, Nathalie Giglioli-Guivarc'h1.   

Abstract

Dominant selectable markers, reporter genes and regulatable systems remain powerful molecular tools for genetic and cell biology studies in fungi. Among Saccharomycotina, it is currently accepted that most species belonging to the genus Candida have adopted a specific codon usage, whereby the CTG codon encodes serine instead of leucine. This group is now widely referred to as the CTG clade. For a long time, this uncommon genetic code has precluded the use of the available Saccharomyces or bacterial markers and reporter systems for genetic studies in Candida species. Over the last 15 years, increasing effort has been made to adapt drug-resistance markers, fluorescent protein variants, luciferase and recombinase genes to favour their expression in species related to the yeast CTG clade. In addition to the growing set of Candida genome sequences, these codon-optimized molecular tools have progressively opened a window for the investigation of the conservation of gene function within Candida species. These technical advances will also facilitate future genetic studies in non-albicans Candida (NAC) species and will help both in elucidating the molecular events underlying pathogenicity and antifungal resistance and in exploring the potential of yeast metabolic engineering.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282522     DOI: 10.1099/mic.0.055244-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

Review 1.  The Candida pathogenic species complex.

Authors:  Siobhán A Turner; Geraldine Butler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

2.  A TRP5/5-fluoroanthranilic acid counter-selection system for gene disruption in Candida guilliermondii.

Authors:  Emilien Foureau; Marc Clastre; Yoann Millerioux; Andrew J Simkin; Lucie Cornet; Christelle Dutilleul; Sébastien Besseau; Emeline Marais; Céline Melin; Jérôme Guillard; Joël Crèche; Nathalie Giglioli-Guivarc'h; Vincent Courdavault; Nicolas Papon
Journal:  Curr Genet       Date:  2012-05-23       Impact factor: 3.886

3.  Toolbox for Genetic Transformation of Non-Conventional Saccharomycotina Yeasts: High Efficiency Transformation of Yeasts Belonging to the Schwanniomyces Genus.

Authors:  Angela Matanović; Kristian Arambašić; Bojan Žunar; Anamarija Štafa; Marina Svetec Miklenić; Božidar Šantek; Ivan-Krešimir Svetec
Journal:  J Fungi (Basel)       Date:  2022-05-20

4.  Candida guilliermondii: biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics.

Authors:  Nicolas Papon; Vincenzo Savini; Arnaud Lanoue; Andrew J Simkin; Joël Crèche; Nathalie Giglioli-Guivarc'h; Marc Clastre; Vincent Courdavault; Andriy A Sibirny
Journal:  Curr Genet       Date:  2013-04-25       Impact factor: 3.886

5.  Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.

Authors:  Lisa Lombardi; Siobhán A Turner; Fang Zhao; Geraldine Butler
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  Marker Recycling in Candida albicans through CRISPR-Cas9-Induced Marker Excision.

Authors:  Manning Y Huang; Aaron P Mitchell
Journal:  mSphere       Date:  2017-03-15       Impact factor: 4.389

Review 7.  Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm.

Authors:  Nicolas Papon; Vincent Courdavault; Marc Clastre; Richard J Bennett
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

Review 8.  Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy.

Authors:  Summer R Hayek; Samuel A Lee; Karlett J Parra
Journal:  Front Pharmacol       Date:  2014-01-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.